The European Society for Translational Medicine (EUSTM) cordially invites industry partners to attend and apply for the sponsorship opportunities for the Immunotherapeutics 2023 (From Biology to Patients Care) which will be held Virtual during 6-7 May, 2023. This Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care.
The Congresss not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.
The delegates will have access to latest developments and updates by the industry and vendors. Due to interdisciplinary congress, the following slots would provide great opportunity to showcase services/products to global multidisciplinary audience. Following types of opportunities are available on ‘first–come, first–served basis.